{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:32Z","timestamp":1761895892915,"version":"3.40.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.cca.2014.05.019","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T13:12:08Z","timestamp":1401714728000},"page":"237-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests"],"prefix":"10.1016","volume":"436","author":[{"given":"Maria","family":"Infantino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Meacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Benucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.05.019_bb0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"7","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.05.019_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"Van Venrooij","year":"2011","journal-title":"Nat Rev Rheum"},{"key":"10.1016\/j.cca.2014.05.019_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3899\/jrheum.101070","article-title":"Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review","volume":"38","author":"Schoels","year":"2011","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.cca.2014.05.019_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro) filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.05.019_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cca.2012.09.015","article-title":"Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis","volume":"414","author":"Swart","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.05.019_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.05.019_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.05.019_bb0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","article-title":"Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis","volume":"12","author":"Trouw","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2014.05.019_bb0045","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.05.019_bb0050","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/annrheumdis-2011-200693","article-title":"Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies","volume":"71","author":"Bizzaro","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.05.019_bb0055","series-title":"Presented at the AMLI Meeting, Orlando, Florida, August 2010","article-title":"A comparison of the BioPlex 200 anti-CCP assay and the Inova anti-CCP3 IgG assay: clinical sensitivity and specificity for rheumatoid arthritis","author":"Wu","year":"2010"},{"key":"10.1016\/j.cca.2014.05.019_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/03009742.2012.723746","article-title":"Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis","volume":"42","author":"Debaugnies","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cca.2014.05.019_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3899\/jrheum.080656","article-title":"Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid artrhritis","volume":"36","author":"Mutlu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2014.05.019_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10067-008-0999-5","article-title":"A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis","volume":"28","author":"Dos Anjos","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2014.05.019_bb0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2007.071654","article-title":"Do all anti-citrullinated protein\/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein\/peptide antibody tests in patients with and without rheumatoid arthritis","volume":"67","author":"Vander Cruyssen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.05.019_bb0080","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","article-title":"Analytical and diagnostic characteristics of 1st, 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins","volume":"53","author":"Bizzaro","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.05.019_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12016-007-8030-5","article-title":"Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients","volume":"34","author":"Correia","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cca.2014.05.019_bb0090","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"Van der Linden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.05.019_bb0095","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3899\/jrheum.091236","article-title":"Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies","volume":"37","author":"Jaskowski","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2014.05.019_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.autrev.2006.03.008","article-title":"Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis","volume":"6","author":"Van Venrooij","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2014.05.019_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autrev.2010.08.009","article-title":"All you wanted to know about anti-CCP but were afraid to ask","volume":"10","author":"Wiik","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2014.05.019_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2903","article-title":"The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis","volume":"12","author":"Pruijn","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2014.05.019_bb0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/ard.2007.085597","article-title":"Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor","volume":"68","author":"Bossuyt","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.05.019_bb0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2011-200421","article-title":"The ACPA recognition profile and subgrouping of ACPA-positive RA patients","volume":"71","author":"Willemze","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.05.019_bb0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00296-009-1336-2","article-title":"Comparation of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japonase patients with rheumatoid arthritis","volume":"31","author":"Shidara","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2014.05.019_bb0130","first-page":"711","article-title":"Diagnostic utility of anti-citrullinated protein antibody and its comparison with rheumatoid factor in rheumatoid arthritis","volume":"22","author":"Khan","year":"2012","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.cca.2014.05.019_bb0135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.autrev.2012.02.015","article-title":"Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature","volume":"11","author":"Bartoloni","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2014.05.019_bb0140","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00296-012-2469-2","article-title":"The sensitivity, specificity and accuracy of anti-citrulline antibody test in diagnosis of rheumatoid arthritis","volume":"33","author":"Abolghasemi","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2014.05.019_bb0145","first-page":"101","article-title":"Analytical and diagnostic performance of an automated anti-CCP assay","volume":"33","author":"Pavai","year":"2011","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.cca.2014.05.019_bb0150","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cca.2012.02.002","article-title":"Analytical and clinical comparison of anti-CCP assays with rheumatoid factor for the diagnosis of rheumatoid arthritis","volume":"413","author":"Block","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.05.019_bb0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12016-007-8027-0","article-title":"Diagnostic accuracy of immunoassays for the detection of antibodies to citrullinated proteins","volume":"34","author":"Bizzaro","year":"2008","journal-title":"Clin Rev Allerg Immunol"},{"key":"10.1016\/j.cca.2014.05.019_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10875-011-9610-y","article-title":"Second generation automated anti-CCP test better predicts the clinical diagnosis of rheumatoid arthritis","volume":"32","author":"Elrefaei","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cca.2014.05.019_bb0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4081\/reumatismo.2012.321","article-title":"Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease","volume":"64","author":"Taraborelli","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.cca.2014.05.019_bb0170","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-008-0570-3","article-title":"The association of anti-CCP antibodies with disease activity in rheumatoid arthritis","volume":"28","author":"Serdaro\u011flu","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2014.05.019_bb0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-008-0527-6","article-title":"Early rheumatoid arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe)","volume":"28","author":"Benucci","year":"2008","journal-title":"Rheumatol Int"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:56:23Z","timestamp":1746251783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":35,"alternative-id":["S0009898114002393"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.05.019","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}